Chandrasekaran, K.; Choi, J.; Arvas, M.I.; Salimian, M.; Singh, S.; Xu, S.; Gullapalli, R.P.; Kristian, T.; Russell, J.W.
Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. Int. J. Mol. Sci. 2020, 21, 3756.
https://doi.org/10.3390/ijms21113756
AMA Style
Chandrasekaran K, Choi J, Arvas MI, Salimian M, Singh S, Xu S, Gullapalli RP, Kristian T, Russell JW.
Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. International Journal of Molecular Sciences. 2020; 21(11):3756.
https://doi.org/10.3390/ijms21113756
Chicago/Turabian Style
Chandrasekaran, Krish, Joungil Choi, Muhammed Ikbal Arvas, Mohammad Salimian, Sujal Singh, Su Xu, Rao P Gullapalli, Tibor Kristian, and James William Russell.
2020. "Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons" International Journal of Molecular Sciences 21, no. 11: 3756.
https://doi.org/10.3390/ijms21113756
APA Style
Chandrasekaran, K., Choi, J., Arvas, M. I., Salimian, M., Singh, S., Xu, S., Gullapalli, R. P., Kristian, T., & Russell, J. W.
(2020). Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. International Journal of Molecular Sciences, 21(11), 3756.
https://doi.org/10.3390/ijms21113756